Astra Biotech

Executive Summary

Astra Biotech GmbH, founded in 2009 and based in Berlin, Germany, is a specialized provider of in vitro diagnostics (IVD) reagents and diagnostic kits. The company serves both direct laboratory customers and original equipment manufacturers (OEM) in the biomedical industry. With a focus on high-quality products, Astra Biotech has steadily expanded its portfolio since inception. The company operates as a private entity, with no public disclosures on funding, valuation, or revenue. Despite limited public visibility, its position in the diagnostics market—particularly the OEM segment—suggests a steady demand for its products. The company’s future growth hinges on expanding its product range, securing new OEM partnerships, and navigating regulatory requirements in the EU and beyond. As the diagnostics sector continues to grow, Astra Biotech is well-positioned to capitalize on trends such as personalized medicine and decentralized testing.

Upcoming Catalysts (preview)

• Q4 2026Launch of new diagnostic kit for infectious diseases60% success
• H1 2027Expansion into Asian markets through OEM partnerships50% success
• TBDStrategic acquisition or collaboration to broaden technology platform35% success